Trials
| CRISPR Medicine | This is an overview of articles on trials
Sign-up to weekly Newsletter here.
Trials
| CRISPR Medicine | This is an overview of articles on trials
Sign-up to weekly Newsletter here.
IND Enabling
Phase I
Phase II
Phase III
Heterozygous familial hypercholesterolemia, (ChiCTR2400093099)
Sponsors:
Primary sponsor: The First Affiliated Hospital of Bengbu Medical College Primary sponsor's address: 287 Changhuai Road, Longzihu District, Bengbu, Anhui, China Secondary sponsor: Country: China Province: Anhui City: Bengbu Institution hospital: The First Affiliated Hospital of Bengbu Medical College Address: 287 Changhuai Road, Longzihu District
Sponsors:
Primary sponsor: The First Affiliated Hospital of Bengbu Medical College Primary sponsor's address: 287 Changhuai Road, Longzihu District, Bengbu, Anhui, China Secondary sponsor: Country: China Province: Anhui City: Bengbu Institution hospital: The First Affiliated Hospital of Bengbu Medical College Address: 287 Changhuai Road, Longzihu District
IND Enabling
Phase I
Phase II
Phase III
Relapsed or refractory B-cell hematological malignancies, (NCT05381181)
Sponsors:
Bioray Laboratories
Sponsors:
Bioray Laboratories
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma, (NCT06934382)
Sponsors:
Stephan Grupp MD PhD, Children's Hospital of Philadelphia
Sponsors:
Stephan Grupp MD PhD, Children's Hospital of Philadelphia
IND Enabling
Phase I
Phase II
Phase III